NCT07745972 Ultrasound-Guided Recto-Intercostal Fascial Plane Block in Laparoscopic Cholecystectomy
| NCT ID | NCT07745972 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istinye University |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-08-06 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-08-06 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to reduce postoperative pain by performing rectointercostal block in L/S cholecystectomy surgeries. Main goal is to provide well managed post-operative analgesia.
Eligibility Criteria
Inclusion Criteria: * BMI \< 35 kg/m² * Patients with ASA scores I and II Exclusion Criteria: * Patients who do not want to be included in the study * Psychiatric and neurological disease with blurred consciousness * Patients with ASA \> 3 * BMI \> 35 kg/m² * Abnormality in coagulation parameters * History of allergy to local anesthetic drugs * Infection at the injection site
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07745972 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07745972 currently recruiting?
Yes, NCT07745972 is actively recruiting participants. Contact the research team at bora.bilal@istinye.edu.tr for enrollment information.
Where is the NCT07745972 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07745972 clinical trial?
NCT07745972 is sponsored by Istinye University. The trial plans to enroll 60 participants.